The FMR1 CGG repeat as functional element and therapeutic target in Fragile X associated disorders
FMR1 CGG 重复序列作为脆性 X 相关疾病的功能元件和治疗靶点
基本信息
- 批准号:10669050
- 负责人:
- 金额:$ 50.83万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-09-25 至 2025-06-30
- 项目状态:未结题
- 来源:
- 关键词:5&apos Untranslated RegionsAntisense OligonucleotidesBiological AssayBiological ModelsCGG repeatCGG repeat expansionCRISPR/Cas technologyCell LineDataDendritesDiseaseElementsFMR1FMR1 repeatFMRPFXTASFragile X PremutationFragile X SyndromeGene Expression RegulationGenetic TranscriptionGoalsHumanHuman GenomeImpairmentInheritedInitiator CodonIntellectual functioning disabilityKnock-in MouseLearningLong-Term DepressionMemoryMetabotropic Glutamate ReceptorsMicrosatellite RepeatsModelingMusNerve DegenerationNeurobiologyNeuronal PlasticityNeuronsOpen Reading FramesPathogenesisPathway interactionsPatientsPhenotypePhosphorylationPhysiologic pulsePlayProcessProtein BiosynthesisProteinsReceptor ActivationRegulationRepetitive SequenceReporterRoleSeriesShort Tandem RepeatSiteSmall Interfering RNASynaptic plasticitySystemTestingTranslational RepressionTranslationsage related neurodegenerationautism spectrum disordercryptic proteingenome-widehuman diseasehuman embryonic stem cellimprovedinduced pluripotent stem cellinnovationmouse modelnervous system disordernovel strategiesnovel therapeuticspreventresponsesynaptic functiontherapeutic developmenttherapeutic targettool
项目摘要
The FMR1 repeat as functional element and therapeutic target in Fragile X disorders.
Short Tandem repeat (STR) expansions cause ~50 inherited neurological diseases. However,
disease associated loci represent only a small fraction of the ~3 million STRs present in the
human genome. Despite their importance in human disease, the broader question of what
intrinsic roles these repetitive elements play in normal neurobiology is largely unexplored. We
recently discovered a conserved and native function for CGG repeats in the 5’ UTR of FMR1.
This repeat expands in Fragile X Syndrome (FXS, a common cause of autism and intellectual
disability) and Fragile X-associated Tremor/Ataxia Syndrome (FXTAS, an age related
neurodegenerative disorder). At normal and expanded sizes, FMR1 CGG repeats trigger
translation of multiple cryptic proteins in the absence of an AUG start codon (CGG RAN
translation). We recently described how CGG repeats and RAN translation act as an upstream
open reading frame (uORF) to impede translation of the fragile X protein, FMRP. Using a
combination of reporter assays as well as RAN translation blocking antisense oligonucleotides
(RAN ASOs) in human neurons, we found that both the CGG repeats and RAN translation
inhibit FMRP synthesis basally. This inhibition is alleviated by metabotropic glutamate receptor
(mGluR) activation, which underlies a form of synaptic plasticity important for learning and
memory and implicated in Fragile X-associated disorders. Based on these findings, our central
hypothesis is that RAN translation and tandem microsatellite repeats have native functions in
the regulation of the genes in which they reside, and that aberrancies in these native functions
contribute to human disease. Our goals in this project are 3 fold: 1) Determine the mechanisms
by which CGG repeats and RAN translation regulate FMRP synthesis, 2) investigate what
consequences result from disrupting this regulatory loop in both mouse models and human
neurons, and 3) evaluate whether ASOs can be used to simultaneously suppress RAN
translation and activate FMRP synthesis in FXS and FXTAS human neurons as a step towards
novel therapeutic development.
FMR1在脆弱的X疾病中重复作为功能元件和治疗靶标。
短串联重复(STR)膨胀导致〜50种遗传神经局部疾病。
与疾病相关的基因座仅占约300万个Str中的一小部分
人类基因组,尽管在人类疾病中很重要
固有的角色在正常的神经生物学中发挥作用
最近在FMR1的5'UTR中发现了CGG重复的保守和天然函数。
这种重复症在脆弱的X综合征中扩展(FXS,自闭症和智力的常见原因
残疾)和脆弱的X相关震颤/共济失调综合征(FXTAS,ANGE相关
神经退行性障碍)。
在没有Aug Start密码子(CGG RAN)的情况下,多种隐秘蛋白的翻译
翻译)。
开放式阅读框(UORF)阻碍了脆弱X蛋白FMRP的翻译。
记者分析的组合屁股和lanslation阻止反义寡核苷酸
(在人类神经元中进行ASOS),我们。
抑制FMRP的合成基本上是由代谢性谷氨酸受体缓解的
(mglur)激活,它的基础是一种突触塑料形式,对学习和学习很重要
记忆并与X相关的疾病与我们的中心相关。
假设是,lansalation和串联微卫星重复性具有天然功能
对其居住的基因的调节,以及TESE本地功能中的畸变
为人类疾病做出贡献。
通过该CGG重复和lanslation调节FMRP合成,2)研究什么
后果是由于破坏了小鼠穆斯和人的规律性循环而导致的后果
神经元和3)评估是否可以使用ASO同时抑制RAN
FXS和FXTAS人神经元中的FMRP合成并激活FMRP合成,作为迈向的一步
新颖的治疗发展。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Peter K Todd其他文献
Peter K Todd的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Peter K Todd', 18)}}的其他基金
Repeat associated neurodegeneration in CANVAS
CANVAS 中重复相关的神经变性
- 批准号:
10536010 - 财政年份:2022
- 资助金额:
$ 50.83万 - 项目类别:
Bypassing cellular stress pathways in frontotemporal dementia and ALS
绕过额颞叶痴呆和 ALS 的细胞应激途径
- 批准号:
10553169 - 财政年份:2020
- 资助金额:
$ 50.83万 - 项目类别:
Bypassing cellular stress pathways in frontotemporal dementia and ALS
绕过额颞叶痴呆和 ALS 的细胞应激途径
- 批准号:
10438531 - 财政年份:2020
- 资助金额:
$ 50.83万 - 项目类别:
The FMR1 CGG repeat as functional element and therapeutic target in Fragile X associated disorders
FMR1 CGG 重复序列作为脆性 X 相关疾病的功能元件和治疗靶点
- 批准号:
10271293 - 财政年份:2020
- 资助金额:
$ 50.83万 - 项目类别:
Bypassing cellular stress pathways in frontotemporal dementia and ALS
绕过额颞叶痴呆和 ALS 的细胞应激途径
- 批准号:
9890664 - 财政年份:2020
- 资助金额:
$ 50.83万 - 项目类别:
The FMR1 CGG repeat as functional element and therapeutic target in Fragile X associated disorders
FMR1 CGG 重复序列作为脆性 X 相关疾病的功能元件和治疗靶点
- 批准号:
10451594 - 财政年份:2020
- 资助金额:
$ 50.83万 - 项目类别:
Hexanucleotide repeat translation in ALS and Frontotemporal Dementia
ALS 和额颞叶痴呆中的六核苷酸重复翻译
- 批准号:
9920791 - 财政年份:2016
- 资助金额:
$ 50.83万 - 项目类别:
Hexanucleotide repeat translation in ALS and Frontotemporal Dementia
ALS 和额颞叶痴呆中的六核苷酸重复翻译
- 批准号:
10680134 - 财政年份:2016
- 资助金额:
$ 50.83万 - 项目类别:
CGG repeat associated translation in Fragile X-associated Tremor/Ataxia Syndrome
脆性 X 相关震颤/共济失调综合征中的 CGG 重复相关翻译
- 批准号:
8670071 - 财政年份:2014
- 资助金额:
$ 50.83万 - 项目类别:
CGG repeat associated translation in Fragile X-associated Tremor/Ataxia Syndrome
脆性 X 相关震颤/共济失调综合征中的 CGG 重复相关翻译
- 批准号:
9914611 - 财政年份:2014
- 资助金额:
$ 50.83万 - 项目类别:
相似海外基金
Targeting HNF4-induced thrombo-inflammation in Chagas disease
针对恰加斯病中 HNF4 诱导的血栓炎症
- 批准号:
10727268 - 财政年份:2023
- 资助金额:
$ 50.83万 - 项目类别:
Therapeutic rescue of Polycystin-1 protein expression by targeting PKD1 upstream open reading frames
通过靶向 PKD1 上游开放阅读框来治疗性挽救 Polycystin-1 蛋白表达
- 批准号:
10575251 - 财政年份:2023
- 资助金额:
$ 50.83万 - 项目类别:
uORF-mediated Translational Control of Cardiac Transcription Factor Expression
uORF介导的心脏转录因子表达的翻译控制
- 批准号:
10659430 - 财政年份:2023
- 资助金额:
$ 50.83万 - 项目类别:
Muscle-Specific CRISPR/Cas9 Exon Skipping for Duchenne Muscular Dystrophy Therapeutics
肌肉特异性 CRISPR/Cas9 外显子跳跃用于杜氏肌营养不良疗法
- 批准号:
10679199 - 财政年份:2023
- 资助金额:
$ 50.83万 - 项目类别:
Therapeutic Potential of Rescued FMR1 Mis-Splicing in Fragile X Syndrome
挽救 FMR1 错误剪接对脆性 X 综合征的治疗潜力
- 批准号:
10713600 - 财政年份:2023
- 资助金额:
$ 50.83万 - 项目类别: